Pacira BioSciences reported total revenues of $167.1 million for Q1 2024, with net income of $9.0 million, or $0.19 per share. The company also announced a new $150 million share repurchase program.
Total revenues reached $167.1 million.
EXPAREL net product sales were $132.4 million.
Net income was $9.0 million, or $0.19 per share.
A new $150 million share repurchase program was approved.
The company is reiterating its full-year 2024 financial guidance.
Visualization of income flow from segment revenue to net income
Analyze how earnings announcements historically affect stock price performance